Interestingly, Intranasal insulin, metformin, incretins, and thiazolidinediones are a few examples of anti-diabetic drugs that have been demonstrated in human studies to improve cognition and memory in individuals with mild cognitive impairment and Alzheimer’s disease (Michailidis et al. 2022). This evidence concerns the gene GCG and early-onset autosomal dominant Alzheimer disease.